Alzheimer’s prevention Phase 1 trial will look at safety of nasal vaccine. Much to happen before any conclusions can be drawn from this study. Also, @billcarrolltalk and I also discuss the approval of COVID vaccine for 5-11 year-old children.

Medical Mythbusting Commentary for November 22, 2021


Nasal vaccine to treat Alzheimer’s disease to be tested in U.S. clinical trial

COVID-19 vaccines for children